Skip to main content
Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
3.875
+0.335 (9.46%)
Mar 9, 2026, 3:33 PM EDT - Market open

Altimmune Revenue

In the year 2025, Altimmune had annual revenue of $41.00K with 105.00% growth. Altimmune had revenue of $26.00K in the quarter ending December 31, 2025, with 420.00% growth.

Revenue (ttm)
$41.00K
Revenue Growth
+105.00%
P/S Ratio
11,864.92
Revenue / Employee
$695
Employees
59
Market Cap
504.02M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202541.00K21.00K105.00%
Dec 31, 202420.00K-406.00K-95.31%
Dec 31, 2023426.00K494.00K-726.47%
Dec 31, 2022-68.00K-4.48M-101.54%
Dec 31, 20214.41M-3.78M-46.12%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Vanda Pharmaceuticals 216.11M
REGENXBIO 170.44M
Century Therapeutics 113.34M
Assembly Biosciences 37.19M
Entrada Therapeutics 25.42M
Lineage Cell Therapeutics 14.56M
Lyell Immunopharma 41.00K
Revenue Rankings

ALT News

More News